Utama › Tumor Wilms › Massachusetts
Kajian klinikal Tumor Wilms di Massachusetts
4 kajian untuk Tumor Wilms sedang mencari peserta di lokasi di Massachusetts.
Bandar di Massachusetts
Teks kajian rasmi (Bahasa Inggeris)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 2
Umur 12 hingga 39 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT04616560A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Dana-Farber Cancer Institute, Boston
- UMass Memorial Medical Center - University Campus, Worcester
Mengambil pesertaFasa 2
Sehingga umur 30 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 1/2
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Dana Farber Cancer Institute (Data Collection Only), Boston
Mengambil pesertaFasa 2
12 Months · Semua jantina · Dikemas kini 6 Mei 2026 · NCT05985161Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.